COST-EFFECTIVENESS OF SACRAL NEUROMODULATION VS. BOTOX FOR REFRACTORY URGENCY URINARY INCONTINENCE: RESULTS FROM THE ROSETTA TRIAL

被引：0
|
作者：
Harvie, H. S. [1 ]
Amundsen, C. [2 ]
Neuwahl, S. J. [3 ]
Honeycutt, A. A. [3 ]
Rogers, R. G. [4 ]
Sung, V. W.
Lukacz, E. [5 ]
Ferrando, C. A. [6 ]
Ellington, D. [7 ]
Honeycutt, E. [3 ]
Thomas, S. M. [3 ]
Mazloomdoost, D. [8 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Duke, Philadelphia, PA USA
[3] RTI, Res Triangle Pk, NC USA
[4] Univ New Mexico, Albuquerque, NM 87131 USA
[5] Univ Calif San Diego, San Diego, CA USA
[6] Cleveland Clin, Cleveland, OH USA
[7] Univ Alabama Birmingham, Birmingham, AL USA
[8] NICHD, NIH, Bethesda, MD USA
来源：
NEUROUROLOGY AND URODYNAMICS | 2018年 / 37卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
439
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial
    Harvie, Heidi S.
    Amundsen, Cindy L.
    Neuwahl, Simon J.
    Honeycutt, Amanda A.
    Lukacz, Emily S.
    Sung, Vivian W.
    Rogers, Rebecca G.
    Ellington, David
    Ferrando, Cecile A.
    Chermansky, Christopher J.
    Mazloomdoost, Donna
    Thomas, Sonia
    JOURNAL OF UROLOGY, 2020, 203 (05): : 969 - 976
  • [2] Cost-Effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial EDITORIAL COMMENT
    Sutherland, Suzette E.
    JOURNAL OF UROLOGY, 2020, 203 (05): : 976 - 976
  • [3] OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women A Randomized Clinical Trial
    Amundsen, Cindy L.
    Richter, Holly E.
    Menefee, Shawn A.
    Komesu, Yuko M.
    Arya, Lily A.
    Gregory, Thomas
    Myers, Deborah L.
    Zyczynski, Halina M.
    Vasavada, Sandip
    Nolen, Tracy L.
    Wallace, Dennis
    Meikle, Susan F.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (13): : 1366 - 1374
  • [4] Cost-Effectiveness Analysis of Anticholinergics Versus Botox for Urgency Urinary Incontinence: Results From the Anticholinergic Versus Botox Comparison Randomized Trial
    Visco, Anthony G.
    Zyczynski, Halina
    Brubaker, Linda
    Nygaard, Ingrid
    Xu, Xiao
    Lukacz, Emily S.
    Paraiso, Marie Fidela
    Greer, Jerod
    Rahn, David D.
    Meikle, Susan F.
    Honeycutt, Amanda A.
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2016, 22 (05): : 311 - 316
  • [5] Re: OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial
    Cornu, Jean-Nicolas
    EUROPEAN UROLOGY, 2017, 71 (06) : 988 - 989
  • [6] Re: Cost-Effectiveness Analysis of Anticholinergics versus Botox for Urgency Urinary Incontinence: Results from the Anticholinergic versus Botox Comparison Randomized Trial
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2017, 198 (03): : 487 - 488
  • [7] Re: OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial Comment
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2017, 197 (06): : 1524 - +
  • [8] The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial
    Amundsen, Cindy L.
    Richter, Holly E.
    Menefee, Shawn
    Vasavada, Sandip
    Rahn, David D.
    Kenton, Kim
    Harvie, Heidi S.
    Wallace, Dennis
    Meikle, Susie
    CONTEMPORARY CLINICAL TRIALS, 2014, 37 (02) : 272 - 283
  • [9] The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA Trial
    Hall, Evelyn
    OBSTETRICS AND GYNECOLOGY, 2017, 129 (01): : 201 - 201
  • [10] Sacral Neuromodulation for the Treatment of Fecal Incontinence: Analysis of Cost-Effectiveness
    Indinnimeo, M.
    Ratto, C.
    Moschella, C. M.
    Fiore, A.
    Brosa, M.
    Giardina, S.
    DISEASES OF THE COLON & RECTUM, 2010, 53 (12) : 1661 - 1669
12345